Market success is not dependent upon the multi-year drug development and promised benefits of your drug. Market success is dependent upon Market Access. Navigating today’s shifting healthcare landscape is complicated. Never before has the healthcare industry witnessed such promising treatments entering the marketplace, yet facing so many challenges.
With our holistic approach we evaluate market share and improve pull-through efforts by looking deeply into key plans driving low regional share and performed analyses (e.g., spillover, rejections) to identify opportunities to increase share.
We bring an unrivaled understanding of the reimbursement and cost-and-coverage dynamics that matter to stakeholders, from health plan medical directors to specialty pharmacy. Our capabilities and expertise on pre-launch, launch, and mature products encompass access and reimbursement issues, advocate development, stakeholder education, promotional programs, and sales training communications. We are committed to delivering solutions that support all payer customer channels for our clients.
With ACTICS by EVERSANA, clients can power their market access success through:
Value is achieved with Comprehensive Services, including:
The intelligence you need to validate or inform your strategy across the product life cycle.詳細情報
Assess your pricing and launch strategies globally. Answer the complex questions impacting your revenue.詳細情報
Breaking down the complexity of reimbursement and access. Engaging the Patient, Payer and Provider.詳細情報
Distribution from Day 1 including special logistics for regenerative medicine.詳細情報
Get therapies to patients quickly and effectively. We manage inventory, payer relationships, cash flow and wraparound patient service needs.詳細情報
Help your patients secure treatments by offering options to manage cost.詳細情報
With advancements in big data technologies and the sophistication of health information exchange, payers and providers are building analytic capabilities to identify real world unmet needs, along with areas of cost containment and efficiency. The development of digital medicines, apps, wearables, and biosensors that gather and store large amounts of health-related data has also accelerated. So, given the number of converging factors, how do we ensure that patients have access to the medicines they need, when, and where they need them?